methylphenidate "mylan" 18 mg depottabletter
mylan ab - methylphenidathydrochlorid - depottabletter - 18 mg
methylphenidate "sandoz" 18 mg depottabletter
sandoz a/s - methylphenidathydrochlorid - depottabletter - 18 mg
methylphenidat "orifarm" 27 mg depottabletter
orifarm a/s - methylphenidathydrochlorid - depottabletter - 27 mg
methylphenidat "2care4" 18 mg depottabletter
2care4 aps - methylphenidathydrochlorid - depottabletter - 18 mg
methylphenidate "medical valley" 18 mg depottabletter
medical valley invest ab - methylphenidathydrochlorid - depottabletter - 18 mg
dimethyl fumarate mylan
mylan ireland limited - dimethylfumarat - multipel sklerose, recidiverende-remitterende - immunosuppressiva - dimethyl fumarate mylan is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis.
dimethyl fumarate neuraxpharm
laboratorios lesvi s.l. - dimethylfumarat - multipel sklerose, recidiverende-remitterende - immunosuppressiva - dimethyl fumarate neuraxpharma is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis.
dimethyl fumarate teva
teva gmbh - dimethylfumarat - multiple sclerosis, relapsing-remitting; multiple sclerosis - immunosuppressiva - dimethyl fumarate teva is indicated for the treatment of adult and paediatric patients aged 13 years and older with relapsing remitting multiple sclerosis (rrms).
dimethyl fumarate accord
accord healthcare s.l.u. - dimethylfumarat - multiple sclerosis, relapsing-remitting; multiple sclerosis - immunosuppressiva - dimethyl fumarate accord is indicated for the treatment of adult and paediatric patients aged 13 years and older with relapsing remitting multiple sclerosis (rrms).
methylphenidate "actavis" 27 mg depottabletter
actavis group ptc ehf. - methylphenidathydrochlorid - depottabletter - 27 mg